Testing for hepatitis B infection in prospective chemotherapy patients: A retrospective study

doi:10.3748/wjg.v19.i6.923

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6180)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

366

HTML

3107

Figures (1-1)

134

Tables (1-4)

146

Sum=3753

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1059

Download

1368

Sum=2427

Feb 14, 2013 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2013; 19(6): 923-930
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.923

Table 3 Prevalence of hepatitis B virus serum markers and DNA in 2770 patients n (%)

	No.	HBsAg+	HBsAb+	HBeAg+	HBeAb+	Isolated HBcAb+	HBV-sm positive¹	Screening HBV DNA²
Total	2770	372 (13.4)	1367 (49.4)	43 (1.6)	600 (21.7)	284 (10.3)	656 (23.7)	177 (27.0)
Age (yr)
≤ 20	27	2 (7.4)	14 (51.9)	1 (3.7)	2 (7.4)	1 (3.7)	3 (11.1)	1 (33.3)
>20	2743	370 (13.5)	1353 (49.3)	42 (1.5)	598 (21.8)	283 (10.3)	653 (23.8)	176 (27.0)
Sex
Women	1495	144 (9.6)	780 (52.2)	15 (1.0)	280 (18.7)	146 (9.8)	290 (19.4)	52 (17.9)
Men	1275	228 (17.9)	587 (46.7	28 (2.2)	320 (25.5)	138 (10.8)	366 (28.7)	125 (34.2)
Types of tumor
Hematological	134	21 (15.7)	51 (38.1)	3 (2.2)	26 (19.4)	7 (5.2)	28 (20.9)	23 (82.1)
Solid	2636	351 (13.3)	1316 (49.9)	40 (1.5)	574 (21.8)	277 (10.5)	628 (23.8)	154 (24.5)
Liver cancer	177	114 (64.4)	45 (25.4)	17 (9.6)	114 (64.4)	27 (15.3)	141 (79.7)	68 (48.2)
Others	2459	207 (8.4)	1271 (41.7)	23 (0.9)	114 (64.4)	250 (10.2)	487 (19.8)	84 (3.5)

¹HBV-sm positive: HBV serological marker positive (HBsAg positive and/or isolated HBcAb positive);

²Percentage equals the screening number of HBV DNA/number of HBV-sm positive. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBsAb: Hepatitis B surface antibody; HBeAg: Hepatitis B e antigen; HBeAb: Hepatitis B e antibody; HBcAb: Hepatitis B core antibody.

Citation: Wang Y, Luo XM, Yang D, Zhang J, Zhuo HY, Zhang J, Jiang Y. Testing for hepatitis B infection in prospective chemotherapy patients: A retrospective study. World J Gastroenterol 2013; 19(6): 923-930
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/923.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i6.923